XISTA Science Ventures is a venture capital firm dedicated to transforming cutting-edge science into impactful businesses. Rooted in the Institute of Science and Technology Austria (ISTA), it invests in early-stage deep-tech and life science academic spin-offs across Austria, the DACH region, and beyond.
They made 4 investments in the last 12 months. Their most common stage is seed (43% of deals).
Portfolio
14
Fund Size
—
Top Stage
Seed
Last 12 Mo
6
Team
FR
Florian Resch
Managing Partner
AS
Alexander Schwartz
Partner
IK
Ingrid Kelly Spillmann
Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
14 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Seed | — | Jul 2026 | |
| Seed | — | Jun 2026 | |
| Unknown | — | Mar 2026 | |
| Series A | $11M | Jan 2026 | |
| Pre-Seed | — | Jan 2026 | |
| Seed | — | Dec 2025 | |
| GG.ST Antivirals | Series A | — | Jan 2024 |
| Pre-Seed | — | Oct 2023 | |
| Series A | $19.4M | May 2023 | |
| Seed | — | — | |
| Seed | — | — | |
| HHEPHAISTOS Pharma | Seed | — | — |
| Unknown | — | — | |
| IINVISIBLE-LIGHT LABS GMBH | Unknown | — | — |
Top Co-Investors
Constructor Capital2 shared
2bX2 shared
High-Tech Gründerfonds2 shared
Speedinvest1 shared
Ventech1 shared
KOMPAS VC1 shared
Segnalita1 shared
Working Capital Fund1 shared
Creandum1 shared
seed + speed Ventures1 shared
Gateway Ventures1 shared
Hermann Hauser Investment1 shared
PhotonVentures1 shared
Moveon Technologies1 shared
Matterwave Ventures1 shared
Bayern Kapital1 shared
b2venture1 shared
Bek Ventures1 shared
SOSV1 shared
Greencode Ventures1 shared
Last updated: 9 September 2026
